Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

User Photo
kidneycancer

10 months
43 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Leigh Ellis Department of Oncologic Pathology Dana-Farber Cancer Institute Harvard Medical School presents Using Epigenetic Therapy to Enhance Immunotherapy Response in RCC

Filmed at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Up Next Autoplay